BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20567095)

  • 1. [An antiemetic guideline for patients with malignancies in Japan].
    Takeuchi H; Saeki T
    Gan To Kagaku Ryoho; 2010 Jun; 37(6):976-979. PubMed ID: 20567095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A guideline for antimetics use for patients with malignancies].
    Horie Y; Boku N
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1163-8. PubMed ID: 22902437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy-induced nausea and vomiting. Easing patients' fear and discomfort with effective antiemetic regimens.
    Bilgrami S; Fallon BG
    Postgrad Med; 1993 Oct; 94(5):55-8, 62-4. PubMed ID: 8415336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.
    Jordan K; Sippel C; Schmoll HJ
    Oncologist; 2007 Sep; 12(9):1143-50. PubMed ID: 17914084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Emetogenic potential of antineoplastic agents based on clinical trials in Japan].
    Watanabe T; Handa S; Kato Y
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):335-41. PubMed ID: 25812503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of antiemetic drugs.
    Jordan K; Schmoll HJ; Aapro MS
    Crit Rev Oncol Hematol; 2007 Feb; 61(2):162-75. PubMed ID: 17208005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nausea and vomiting with high-dose chemotherapy and stem cell rescue therapy: a review of antiemetic regimens.
    Trigg ME; Inverso DM
    Bone Marrow Transplant; 2008 Oct; 42(8):501-6. PubMed ID: 18724391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
    Herrstedt J
    Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiemetics: an update and the MASCC guidelines applied in clinical practice.
    Herrstedt J
    Nat Clin Pract Oncol; 2008 Jan; 5(1):32-43. PubMed ID: 18097455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiemetic study design: a discussion of Dr Olver's paper.
    Groshen S
    Br J Cancer Suppl; 1992 Dec; 19():S35-7. PubMed ID: 1467199
    [No Abstract]   [Full Text] [Related]  

  • 13. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myths and realities of antiemetic treatment.
    Martin M
    Br J Cancer Suppl; 1992 Dec; 19():S46-50; discussion S50-3. PubMed ID: 1467202
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiemetic guidelines: creating a more practical treatment approach.
    Koeller JM; Aapro MS; Gralla RJ; Grunberg SM; Hesketh PJ; Kris MG; Clark-Snow RA
    Support Care Cancer; 2002 Oct; 10(7):519-22. PubMed ID: 12324805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the emetogenicity of cancer chemotherapy regimens: relevance to clinical practice.
    Hesketh PJ
    Oncologist; 1999; 4(3):191-6. PubMed ID: 10394587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A survey of antiemetic use in children with cancer.
    van Hoff J; Hockenberry-Eaton MJ; Patterson K; Hutter JJ
    Am J Dis Child; 1991 Jul; 145(7):773-8. PubMed ID: 2058609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
    Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiemetic therapy in patients treated with cisplatin chemotherapy.
    Roila F; Basurto C; Bracarda S; Del Favero A; Tonato M
    J Chemother; 1989 Jul; 1(4 Suppl):1281-5. PubMed ID: 16312866
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypnosis in the prevention of chemotherapy-related nausea and vomiting in children: a prospective study.
    Jacknow DS; Tschann JM; Link MP; Boyce WT
    J Dev Behav Pediatr; 1994 Aug; 15(4):258-64. PubMed ID: 7798371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.